RituximabPneumonia following off label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1779卷 / 1期

关键词：

D O I：

10.1007/s40278-019-71471-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：207 / 207

相关论文

共 50 条

[31] RituximabPancytopenia following off-label use: case report
Reactions Weekly, 2020, 1807 (1) : 176 - 176
[32] TocilizumabAnaphylaxis following off-label use: case report
Reactions Weekly, 2021, 1865 (1) : 397 - 397
[33] DexamethasoneHyperglycaemia following off-label use: case report
Reactions Weekly, 2022, 1896 (1) : 173 - 173
[34] CurcuminLack of efficacy following off label use: case report
Reactions Weekly, 2022, 1930 (1) : 212 - 212
[35] AntipsychoticsVarious toxicities following off label use: case report
Reactions Weekly, 2020, 1811 (1) : 48 - 48
[36] DexamfetamineHypertension following off-label use: case report
Reactions Weekly, 2021, 1883 (1) : 150 - 150
[37] FavipiravirNephrotoxicity following off-label use: case report
Reactions Weekly, 2022, 1929 (1) : 283 - 283
[38] RomidepsinLack of efficacy following off label use: case report
Reactions Weekly, 2022, 1922 (1) : 524 - 524
[39] RituximabAsymptomatic neutropenia following off label use: case report
Reactions Weekly, 2021, 1866 (1) : 337 - 337
[40] MirtazapineTachyphylaxis following off-label use: case report
Reactions Weekly, 2018, 1703 (1) : 182 - 182

← 1 2 3 4 5 →